Ask Indegene (Beta)
Hello, how can I help you today?
You may type your question or choose from the options below:
Thank you!
We'll be in touch. In the meantime, feel free to keep exploring!
#PractitionerLevelConfidence
30 Oct 2025
Executive Summary
As generative AI (GenAI) technology revolutionizes user experience (UX) design, its transformative potential within the pharmaceutical industry is profound. However, weaving AI innovation into pharma's highly regulated, deeply human-centric environment requires far more than algorithmic power. It demands a strategic evolution centered on expert-led design to drive the future of experiences, merging multidisciplinary knowledge encompassing psychology, usability, accessibility, aesthetics, empathy, and ethical governance with advanced design tool mastery.
This white paper offers an expansive, data-driven exploration of GenAI's role in reshaping pharma UX, highlighting why "anyone can design with AI" assumptions risk overlooking the intricate human, scientific, and technological realities of pharma. It clarifies why "accessible-to-all" AI tools serve more as ideation aids but are insufficient for production-grade pharma UX, reinforcing the imperative for professional UX designers as strategic and visionary stewards. Experience designers will soon be required to hone strong, protean, multidisciplinary expertise and domain mastery to guide the nuanced interaction of technology and humanity. Developers, in parallel, will evolve as automation stewards, operationalizing design and experience vision.
Rooted in empirical research and global consulting data, this paper reveals a future where generative AI's power is nurtured and wielded like a samurai master's blade, advancing pharma UX as a living synthesis of the convergence of human-centered science and technology.
Why Professional Mastery Still Matters in the Age of GenAI
GenAI catalyzes a plethora of opportunities within the pharmaceutical UX ecosystem: from automating content creation, to personalizing patient journeys and accelerating iterative design. Yet, the application of AI in UX design entails challenges unique to the sector's medical, regulatory, and ethical complexities.
The "accessible-to-all" narratives that currently cloud this domain risk undermining a deeper truth: That truly impactful pharma UX demands:
Profound mastery across multiple knowledge domains
Meticulous attention to nuances demanded at the nexus of emotional intelligence, empathy, subject matter expertise, human psychology, and accessibility
Expert proficiency with industry-grade professional design tools
The Nielsen Norman Group emphasizes "Designers Use AI, Just Not for Design - UX designers actively engaged with text-based AI tools such as ChatGPT for brainstorming and ideation tasks, but we found zero design-specific AI tools in serious use by the professional UX designers we spoke with."
How UX Designers Use AI Today
Many UX designers leverage AI; particularly text-based tools like ChatGPT, Claude, Gemini, or Copilot for:
Ideation and brainstorming
Auxiliary tasks such as generating copy or suggesting feature names
Supporting tasks rather than executing direct design work
AI is especially useful for tasks that don't demand precision or high trust: UX designers employ it for communicating, organizing tasks, generating initial ideas, and occasionally automating basic documentation. This allows practitioners to bridge workflow gaps, bypassing delays that might require specialized collaborators for routine deliverables.
Read more about the role of AI in reshaping life sciences UX design systems.
In contrast, AI-specific tools promising end-to-end design integration have yet to cross the threshold into everyday professional usage. Evaluations and designer feedback indicate that current AI-based design tools and plugins add limited functional value to the design process and often introduce new friction in larger organizational settings. Challenges include inadequate customer support, lack of workflow guidance, and emerging ethical considerations around IP and licensing.
A core reason for skepticism is reliability. AI-generated results, whether for UI components or copy, tend to be variable and inconsistent. This output diversity can aid ideation but poses challenges for replicability, precision, and professional-grade implementation, which are qualities essential for integrating tools into structured design workflows. These tools are more a “solution in search of a problem” than genuine solutions to UX bottlenecks. In larger deployments, issues of ethical use and legal risk further hamper adoption, especially around copyright and attribution for AI-generated content.
Current-generation AI tools are non-deterministic: the same prompt can yield very different results. This complicates dependable use in professional pipelines. While improvements in prompt engineering and underlying models may help yield more reliable, precise, and controlled experiences in the future, the current consensus among UX professionals is clear: AI tools do not yet deliver the precision, trust, or workflow stability needed for end-to-end design processes. Improved alignment with true design problems, reliability, and professional oversight are still required for these tools to become mainstream in UX.
Why 'accessible-to-all' AI Tools Are Not Enough for Pharma UX
While platforms like Replit, Lovable, and Bolt AI help democratize AI-powered prototyping, enabling rapid experimentation through user-friendly interfaces and code generation assistance, their real value lies in faster concept validation. However, these tools serve mostly ideation use cases in the hands of most users and as a result, these efforts end up missing several critical dimensions essential in pharma and life sciences resulting in shallow experiences that would need further experiential granularization and refinement:
Regulatory compliance: Lacking annotations and documentation workflows needed for HIPAA, FDA, and GDPR compliance
Full accessibility features: Absence of integrated accessibility validations to meet WCAG 2.1 and other standards.
Scalability and collaboration: Insufficient support for global, multidisciplinary team workflows, version control, and component libraries.
Contextual complexity: Pharma UX must factor in expansive clinical, psychological or cultural context needed to drive successful experiences. This is critical to avoid adverse user experiences or unintended misinterpretations that could result in negative outcomes. This challenge stems from the deep complexity and diversity of user needs, regulatory constraints, and the need for deep awareness of emotional states in pharma domains
Conversational nuance: Effective AI interaction necessitates deeply researched, context-rich conversational prompts rather than shallow, generic queries
Lacking in depth: AI tools lack depth for advanced interaction design, detailed branding, accessibility compliance, and nuanced, domain-specific design
Need for significant oversight: They often require manual fixes and exports to industry-standard, professional UI/UX design tools like for refinement, failing to deliver the polish needed for regulated industries or custom experience requirements
AI tools aren't equipped to replace strategic design thinking, ethical review, or complex research synthesis. These roles are core to expert UX practitioners and the platforms they use for industry-ready experience design.
Reports highlight that pharma executives emphasize deep domain expertise and interdisciplinary collaboration as decisive factors for digital transformation and experiential success. This underscores why designer expertise cannot be bypassed. Notably, about 73% of pharma digital transformation efforts globally fail, not because of technical challenges, but because they overlook a fundamental truth about pharmaceutical organizations. Many organizational teams attempt to transform technology instead of transforming how people work with technology. Approximately, the 27% that do succeed, have flipped this equation: they design their innovation and transformation efforts by prioritizing stakeholder orchestration first and selecting technology to actualize those efforts second.
In stark contrast, industry-standard professional UI/UX design platforms such as Adobe XD offer comprehensive, compliance-aware design system capabilities that enable pharma UX teams to build adaptable, accessible, and fully governed experiences at scale.
Multidisciplinary Experience Design: The Cornerstone of Pharma UX
Psychology and Understanding User Minds
Deep understanding of cognitive processes, emotional drivers, and behavioral science is foundational and UX designers are at the core of applying this expertise to shape meaningful pharma experiences. When crafting pharma and life sciences solutions, they leverage psychological insights to reduce patient anxiety, build adherence, and foster trust.
The science of incremental stickiness explains how gradual engagement fosters sustained behavior change. Pharmaceutical apps using micro-interactions, motivational nudges, and real-time feedback loops demonstrate increased therapy adherence. These can also play an important role in reducing treatment costs and relieving the burden on the overall health care ecosystem.
Accessibility and Inclusion
With over 1.3 billion people globally living with disabilities, accessible digital healthcare is both a moral imperative and a legal requirement. Deep expertise allows designers to integrate multiple accessibility channels like screen readers, voice control, adaptable typography, beyond automated checks.
The NIH/PMC study on AI and accessibility confirms AI that alone cannot guarantee inclusive UX without expert human validation in context-rich pharma and life sciences environments.
Aesthetics, Typography, and Design Science
Expertise in driving subtlety across aspects such as visual cues, color theory, spatial hierarchy, and legibility critically affect patient comfort and comprehension, which are directly linked to health outcomes. A UX/UI/CX strategy in pharma demands expertise in visual semiotics and typography to create soothing, credible interfaces that reduce cognitive load and facilitate better decision making.
Empathy as a Science
Empathy is systematized into the design process: capturing emotional contexts, pain points, and user aspirations through qualitative and quantitative research.
Harvard Business Review states businesses embedding empathy in design generate significantly more user engagement and loyalty and McKinsey says CX without well thought-through design only gets you halfway. They also say design, that is research-driven, dives deep into user needs and wants through the process of observational research, in-depth interviews, and immersive journey re-creation.
By putting empathy and understanding at the heart of design research, companies reduce risk in the idea-generating phase and ensure the customer remains at the center of the process. Understanding how users as people experience things allows companies to identify unmet needs, so that they can bring genuine value to consumers and cement pathways to commercial success.
PWC talks about how a UX/UI/CX strategy driven by gathering qualitative and quantitative data about our customers' needs, whether met, unmet, or predicted, enables teams to be smarter and more proactive, in tailoring their services and experience strategies.
This approach eliminates guesswork and fosters data-driven decision-making. If we can centrally visualize this data for both patients and HCPs, a clearer picture emerges, paving the way for harmony in care delivery. This in turn could lead to exceeding patient expectations and empowering HCPs to focus on empathetic, insightful care, ultimately transforming how care as a concept, is perceived and delivered.
Left-Brain and Right-Brain Integration
Effective pharma UX bridges analytical rigor with creative intuition.
Left-brained processes enable data-driven decision making and compliance adherence.
Right-brained faculties bring storytelling, emotional resonance, and innovative problem-solving.
Only professionals who synthesize both modes will be able to craft regulatory-compliant yet deeply engaging patient experiences.
Why Mastery of Professional Design Tools is Indispensable
Designers with advanced skills in industry-standard professional design tools are, and will only become more indispensable, going forward. Experienced designers who are adept at systemic thinking, human centered reasoning and ethical orchestration of automated workflows will serve as critical enablers bridging gaps between human intent and machine capabilities, extending the reach and value of these platforms through their expertise.
Read more about anti-design: a bold new approach that challenges the rigidity of conventional design systems to create more engaging, human-centered digital experiences.
Key roles that AI platforms play in pharma UX:
Complex Component Libraries
For scalable, repeatable, and compliant design consistent across global products.
Real-time Collaborative Features
Facilitating multi-expert iteration and governance.
Integrated Accessibility Checks
Enabling early detection and correction of inclusive issues.
Version Control and Annotation
Are critical for audit trials and regulatory submissions.
AI-enhanced Strategic Capabilities
Where AI-assisted wireframe generation complement human-led strategic concept and product refinement.
McKinsey reports that top-performing pharma digital teams using professional-grade UX tools in combination with GenAI initiatives achieve approximately 20% cost efficiency improvements and 10–20% faster enrollments for clinical trials.
AI's Power: The Need for Experience Design Specialists
AI’s generative potential must be approached as a masterful blade forged over time and wielded by a seasoned expert with the necessary awareness. Complex experience design strategies, products and systems should be maintained by domain experts rather than in the hands of the uninitiated. The analogy extends to:
A caring partner
AI requires stewardship, empathy-driven, nuanced guidance, and responsible application.
Warrior's blade
It grants immense power when handled skillfully but can cause harm if used with limited awareness or neglected in the hands of the uninitiated
This necessitates user experience leadership grounded in deep multidisciplinary knowledge, ethical rigor, and technical mastery to unlock AI's enduring value for pharma and life sciences. User experience designers in this sector must not only possess domain expertise but also embrace a protean, savant-like approach that combines technical skills, behavioral science, aesthetics, and philosophy with contextual empathy for patients, scientists and clinicians.
Their role demands that they:
Collaborate effectively with interdisciplinary teams.
Navigate regulatory, compliance, and ethical standards for design efforts.
Thrive on research-driven design thinking while facilitating knowledge sharing across cross-functional touchpoints to drive evidence-based decisions.
Prioritize transparency and trust in AI workflows, always keeping humans in the loop.
Drive continuous evaluation and iteration using analytics and feedback.
Champion sustainability, accessibility, and digital inclusion.
By doing so, they enable high-impact, trustworthy, and future-ready experience design in regulated, patient-centered digital and phygital environments. The breadth and depth of their expertise make them critically essential custodians of the future of experiences that harness GenAI’s power.
Cognitive and Emotional Intelligence
In pharma, UX designers bridge left-brained analytical rigor with right-brained empathic creativity. This nuanced duality enables them to:
Critically analyze AI outputs for biases, errors, or ethical concerns.
Creatively craft human-centered narratives that resonate emotionally with patients, caregivers, and healthcare professionals.
Adapt interfaces dynamically based on varying cognitive loads and emotional states.
Their work anchors technology within the lived realities of users coping with complex conditions and marks the difference between user engagement and user attrition.
The Science of Incremental User Stickiness
Sustainable user engagement, or stickiness, emerges from an iterative approach to behavioral design and continuous refinement:
Micro-interactions and nudges within pharma apps can help encourage habit formation and medication adherence across user groups.
Intelligent notification timing, driven by AI analysis and designer heuristics, can help mitigate fatigue by smoothing user journeys.
Incremental feature rollouts and A/B testing can help ensure interfaces evolve responsively to real-world feedback.
Statistically, digital properties, portals, apps, and more developed under such rigorous design regimes see approximately 30–40% higher retention rates compared to those lacking behavioral psychology grounding.
Why Industry-Standard Design Tools Are Imperative
Professional UI/UX design tools like Figma and Adobe XD empower designers with advanced capabilities to design, build, and deploy web applications efficiently, with the flexibility for human customization. They include:
01
Comprehensive design systems
Maintain consistency and compliance across large-scale interface properties.
02
Collaborative ecosystems
Enable cross-functional teams globally to iterate rapidly with full traceability.
03
Accessibility plugins integration
Proactively address inclusivity standards early in design.
04
Seamless prototyping and developer handoff
Bridge the gap between design intent and implementation efficiently.
Mastery of such tools is non-negotiable; they are the experience design artisan's forge for shaping AI-powered pharma user journeys into safe, effective, and legally compliant realities.
Read how Figma accelerates innovation in pharma content design processes.
Pharma UX always requires seasoned experts to interpret experience complexity, ensure compliance, and design for human impact.
The Value and Critical Role of Multidisciplinary UX Experts
UX designers today possess a broad and deep skill set spanning multiple disciplines and have become utterly indispensable. These professionals combine advanced scientific rigor with a deep understanding of human behavior, technology and complex regulatory environments, making them critical drivers of innovation and user-centered design in pharma, especially as AI inflections reshape the field of UI/UX.
Their capabilities include:
Creative and print output alongside user-centered research
Designing and conducting sophisticated qualitative and quantitative studies tailored to pharma's unique challenges
Navigating diverse user personas: from patients managing chronic illnesses to HCPs and regulatory stakeholders, uncovering both obvious and latent user needs that drive meaningful design innovation
At the core of their expertise is the integration of behavioral science and human factors engineering. They apply principles from cognitive psychology, decision-making science and human capabilities to craft interfaces that not only comply with stringent safety and regulatory standards but also optimize patients’ medication adherence and reduce cognitive burden. This ensures that designs are both scientifically precise and empathetically aligned with users’ mental models. Their work is deeply data-driven:
Leveraging advanced analytics, A/B testing, and statistical analyses to refine user experiences based on real-world behavior
Collaborating closely with AI and machines harnessing these tools to build adaptive, personalized experiences, while ensuring these technological advances remain accessible and empowering to users.
They stand out as specialists for their ability to bridge the complete umbrella of design disciplines fluidly, while collaborating across medical, regulatory, technical, and business domains to deliver designs that are scientifically accurate, compliant, and user-friendly. Their skill in translating complex scientific data, clinical trial results, and regulatory content into clear, understandable interfaces makes intricate information accessible to diverse pharma audiences, helping users make better health decisions at critical moments.
Moreover, these practitioners demonstrate unique personality types steeped in traits like an affinity for inherently incremental, lifelong learning and adaptability, hence effortlessly keeping pace and leading the charge with fast-moving developments in AI, UX methodologies, pharma regulations, and emerging interaction paradigms such as voice and augmented reality interfaces. They lead with a strategic vision, anticipating UX inflection points driven by AI integration and evolving patient expectations, while championing ethical design principles focused on transparency, privacy, inclusivity and empowerment.
In essence, UI/UX professionals with this expansive interdisciplinary expertise effortlessly adapt to scientific grounding and are uniquely equipped to shape the future of pharmaceutical user experience. Their comprehensive skill set ensures that as AI transforms pharma, patient-centered, scientifically sound design remains at the heart of innovation, ultimately improving pharma digital innovation and strategy, their outcomes and transforming how patients and providers interact with vital treatments and their corresponding technology intersections. They harness AI’s full potential responsibly, crafting experiences that elevate the future of life sciences and healthcare alongside most other spaces.
Developers as Automation Stewards
As AI automates routine coding and testing, developers transition to overseeing AI systems, ensuring stability, scalability, and security. They work closely with UX designers to translate visionary experiences into reliable platforms, maintaining the codebase, and integrating new AI capabilities as they evolve to experience-led-engineering.
Here, the metaphor quoted previously that AI is akin to “a blade of war wielded by the uninitiated versus a master of the art” is an apt reference again. AI’s power requires nurturing care and deliberate mastery:
Designers train AI through well-researched, context-rich conversational prompting that sets clear parameters.
Ethical guardrails, continuous human monitoring, and multidisciplinary collaboration ensure AI augments without overriding human values.
AI becomes a trusted partner, sharpening capabilities without losing sight of user dignity and safety.
Understanding this balance between tools and human expertise sets the stage for another critical question: what aspects of the design process can AI realistically take on and where does human expertise remain irreplaceable?
What Tasks Will AI Automate First?
| Design Phase | Highly Automatable | Moderately Automatable | Least Automatable |
|---|---|---|---|
| Ideation and Exploration | Style variations, color and typography suggestions | Competitive UI pattern search | Problem framing, user empathy mapping |
| Wireframing | Text-to-wireframe generation, layout grids | Responsive resizing | Storyboarding complex user journeys |
| High-fidelity Mock-ups | Asset replacement, image up-scaling | Micro-interaction proposals | Brand-specific art direction |
| User Testing | Heat-map prediction, AI eye-tracking simulation | Sentiment analytics | In-depth qualitative interviews |
| Handoff and Documentation | Code snippet export, spec writing | Token alignment | Cross-team facilitation |
AI may handle routine or pattern-based work, but expert-led, high-stakes UX in pharma cannot be automated. It requires blending science, empathy, and regulation to deliver safe, effective, and meaningful user experiences. This reality raises an important question: how can pharma leaders structure their teams, processes, and investments to ensure AI is harnessed responsibly while maximizing its transformative potential?
Strategic Roadmap for Pharma UX Leaders
For pharma organizations, success in the GenAI era will depend on deliberate choices: building the right teams, embedding ethical oversight, and aligning technology adoption with patient-centric values. Industry wide studies show that organizations with strongly integrated UX and automation teams realize significantly higher innovation velocity and accomplish better risk mitigation.
Some best practices to keep in mind are:
Step 1
Invest heavily in multidisciplinary UX teams
comprising psychologists, accessibility experts, technologists, and designers skilled in advanced tools.
Step 2
Embed continuous education and human-centered design principles
promoting critical thinking beyond certifications.
Step 3
Develop and mandate conversational AI prompting standards
to improve AI outputs aligned to pharma's complexity.
Step 4
Balance AI automation and human oversight
positioning developers as AI stewards and designers as strategic visionaries.
Step 5
Prioritize data-driven continuous optimization
using behavioral analytics platforms combined with qualitative research.
Step 6
Commit to inclusivity and universal design
enabling access for all users irrespective of ability, geography, or literacy.
The Future of Pharma UX
The pharma UX evolution positions designers as visionaries and ethical stewards shaping AI-enhanced experiences through multidisciplinary expertise, and developers as automation stewards ensuring implementation, scalability, and stability of AI-generated code.
The future of pharmaceutical UX in the GenAI era hinges on expert-led design. While “accessible-to-all" tools enable faster prototyping and broaden access to design experimentation, they remain most effective as supportive enablers rather than replacements for the rigor required in pharma UX. For complex, patient-centric, and scientifically grounded environments, professional designers provide the necessary expertise to responsibly channel AI’s power with only certain aspects of the design domain open to automation given human-centric needs.
In this context, developers evolve into custodians of AI automation, while experienced designers stand as vigilant guardians of design-thinking and systems-thinking driven opportunities—balancing analytical rigor with creative insight, refining engagement at every step, and nurturing AI as both a trusted partner. The integration of genAI in pharma UI/UX marks a paradigm shift that demands exceptional expertise. Human-centered design principles ensure that only the appropriate dimensions of design are guided by automation, while core judgment and ethics remain firmly human. The success of this evolution rests with UX leaders who unify psychology, accessibility, aesthetics and ethics with advanced design tool proficiency.
At Indegene, we help life sciences organizations navigate this shift with the right blend of AI, Deep design-led-systems thinking, excellence in ‘leading-edge’ user experience consulting, and Pharma domain knowledge. By aligning technology’s futures with human-driven insight, we enable pharma companies to design experiences that are as safe and compliant as they are purposeful and influential.
Talk to us to learn more.
About the Author
Let's Partner to Commercialize with Confidence
